Renal dysfunction and hyperglycemia in a renal transplant recipient.
Leventhal
B
B
Division of Nephrology, New York Presbyterian Hospital-Weill Medical College of Cornell University, New York, New York 10021, USA.
Soave
R
R
Mouradian
J
J
Cheigh
J S
JS
D000328:Adult; D001706:Biopsy; D003404:Creatinine / Q000097:blood; D004359:Drug Therapy, Combination; D005665:Furosemide / Q000627:therapeutic use; D006417:Hematuria; D006801:Humans; D006943:Hyperglycemia / Q000175:diagnosis*; D016756:Immunoglobulins, Intravenous / Q000627:therapeutic use; D007166:Immunosuppressive Agents / Q000627:therapeutic use; D007676:Kidney Failure, Chronic / Q000601:surgery; D016030:Kidney Transplantation / Q000276:immunology / Q000473:pathology / Q000502:physiology*; D008297:Male; D016853:Muromonab-CD3 / Q000627:therapeutic use; D030361:Papillomavirus Infections / Q000473:pathology*; D011120:Polyomavirus / Q000302:isolation & purification*; D011183:Postoperative Complications; D011241:Prednisone / Q000627:therapeutic use; D014412:Tumor Virus Infections / Q000473:pathology*; D014771:Virion / Q000302:isolation & purification
D016756:Immunoglobulins, Intravenous; D007166:Immunosuppressive Agents; D016853:Muromonab-CD3; D005665:Furosemide; D003404:Creatinine; D011241:Prednisone